Skip to main content

Advertisement

COVID-19 and impact on peer review

As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times.  Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.

Featured article: Annual dialysis data report 2017, JSDT Renal Data Registry

Annual dialysisThe annual survey of the Japanese Society for Dialysis Therapy Renal Data Registry (JRDR) was conducted for 4413 dialysis facilities at the end of 2017; among which 4360 facilities (98.8%) responded to the facility questionnaire, and 4188 (94.9%) responded to the patient questionnaire. 

See this article.

Featured article: Comparison of peritoneal dialysis and hemodialysis as first renal replacement therapy in patients with end-stage renal disease and diabetes: a systematic review

Comparision ofDiabetes has become the most common cause of end-stage renal disease (ESRD) requiring renal replacement therapy (RRT) in most countries around the world. Peritoneal dialysis (PD) is valuable for patients newly requiring RRT because of the preservation of residual renal function (RRF), higher quality of life, and hemodynamic stability in comparison with hemodialysis (HD). 

See this article.

Featured article: Clinical practice guideline for renal rehabilitation: systematic reviews and recommendations of exercise therapies in patients with kidney diseases

ClinicalThe purpose of this report is to provide an evidence-based, best practice summary to optimize the quality, safety and efficacy, and availability of renal rehabilitation service, and to provide care for maximum patient prognosis, quality of life, and satisfaction.

See this article.

Articles

  1. Authors: Hisato Shima, Takehiko Kimura, Takeshi Nishiuchi, Takashi Iwase, Shunji Hashizume, Nobuyuki Takamori, Megumi Harada, Yusuke Higashiguchi, Chiaki Masaki, Taro Banno, Naoki Nagasaka, Ayako Ito, Tomoko Inoue, Manabu Tashiro, Masaaki Nishitani, Kazuhiko Kawahara…

    Content type: Case Report

Upcoming conferences

The 53rd Japanese Society for Clinical Renal Transplantation (JSCRT)
19-21 February 2020, Hamamatsucho Convention Hall

The 65th Annual Meeting of the Japanese Society for Dialysis Therapy
12−14 June 2020, Osaka International Convention Center, RIHGA Royal Hotel Osaka

The 66th Annual Meeting of the Japanese Society for Dialysis Therapy
4-6 June 2021, Pacifico Yokohama

The 26th Annual Meeting of the Japanese Society for Peritoneal Dialysis
19-20 September 2020, Keio Plaza Hotel Tokyo

The 31st Annual Meeting of the Japan Society for Blood Purification Critical Care
17-18 October 2020, Kofu Memorial Day's Hotel

The 32nd Annual Meeting of the Japan Society for Blood Purification Critical Care
2-3 October 2021, Rafre Saitama

The 10th Annual Meeting of the Japanese Society of Renal Rehabilitation
22-23 February 2020, Bellesalle Shinjuku Grand Conferance Center

The 11th Annual Meeting of the Japanese Society of Renal Rehabilitation
20-21 March 2021, Sendai International Center

The 14th Annual Meeting of the Japanese Society of Nephrology and Pharmacotherapy
28-29 November 2020, Awagin Hall Tokushima

Submit your manuscript

RRT logo

Please use the online submission system to submit your manuscript. For all enquiries about the journal, please access the site and click Contact Us.

Aims and scope

Renal Replacement Therapy is a peer-reviewed journal facilitating worldwide discussion of research and issues related to the study of renal replacement therapy.

RRT considers articles on all aspects of hemodialysis, peritoneal dialysis, blood purification, renal transplantation and regenerative medicine. In addition, the journal publishes content in wider fields such as chronic kidney disease (CKD), acute kidney injury (AKI), critical care medicine and intensive care, bone and mineral metabolism, anemia and iron metabolism, infection, cardiac disease, cerebral disease, diabetes mellitus, hypertension, nutrition, and related social issues. Contributions are encouraged from a global perspective across many disciplines.

Overcoming Language Barriers

english editingIf your manuscript could benefit from improvements to the English language, you should have your manuscript reviewed by someone who is fluent in English. For a collection of free resources to help with writing in English please visit here. If you would like professional help, we recommend our affiliates Nature Research Editing Service and American Journal Experts for help with English usage. BMC authors receive 10% off their first submission to either service. Please note that use of an editing service is neither a requirement nor a guarantee of publication.

Society affiliations

Renal Replacement Therapy is the official publication of the following societies:





About the Editor

Prof Takashi Shigematsu, Editor-in-Chief

Prof Shigematsu is currently Professor and Director of the Division of Nephrology, Department of Internal Medicine at the Wakayama Medical University School of Medicine, Japan. He is also Director of Blood purification Medicine, and Clinical Engineering at Wakayama Medical University Hospital, as well as a member of the International Society of Nephrology and the American Society of Nephrology.

His research interests focus on bone and mineral metabolism within chronic kidney disease (CKD). In addition, he has been investigating and working in fields of hemodialysis, peritoneal dialysis, blood purification medicine in acute kidney injury, kidney transplantation.

Advertisement

Annual Journal Metrics

  • Speed
    37.6 days to first decision for reviewed manuscripts only
    28.5 days to first decision for all manuscripts
    118.9 days from submission to acceptance
    25 days from acceptance to publication

    Usage 
    210,852 Downloads
    33 Altmetric mentions

Advertisement